Navigation Links
Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011
Date:7/19/2011

UNION CITY, Calif., July 19, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter of fiscal year 2012, ended June 30, 2011. The call will be at 4:15 p.m. ET on Thursday, July 28, 2011.  The Company will report financial results for the first quarter of fiscal year 2012 after the market closes on Thursday, July 28, 2011.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10002131, through August 3, 2011.

About AbaxisAbaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs or rotors, which contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections in dogs, Parvovirus and Giardia. Abaxis is also in the final stages of building a full-service laboratory testing facility for veterinarians, focusing on specialty and esoteric testing and analysis.  This state-of-the-art commercial laboratory will be the hub of the Abaxis Veterinary Reference Laboratories (AVRL).Contact:

Clint Severson

Lytham Partners, LLCChief Executive Officer

Joe Dorame, Joe Diaz & Robert BlumAbaxis, Inc.

602-889-9700510-675-6500
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test
2. Abaxis to Report Second Quarter Fiscal 2010 Financial Results Tuesday, October 27, 2009
3. Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010
4. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
5. Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Abaxis, Inc. to Present at Sidoti & Companys Ninth Annual West Coast Institutional Investor Forum
7. Abaxis to Report Second Quarter Fiscal 2011 Financial Results Tuesday, October 26, 2010
8. Abaxis Reports Financial Performance with Record Sales for the Second Quarter of Fiscal 2011
9. Abaxis, Inc. to Present at Stephens Fall Investment Conference
10. Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus
11. Abaxis to Report Third Quarter Fiscal 2011 Financial Results Thursday, January 27, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... York , May 4, 2016 ... Transparency Market Research entitled "Brain Computer Interface Market - Global ... - 2024," the  global brain computer interface (BCI) market  is ... 2024. The market is estimated to expand at a ... 2016 to 2024. A BCI device provides ...
(Date:5/4/2016)... NESS ZIONA, Israel , May ... BVXV, TASE: BVXV) announced today that BiondVax,s CEO, Dr. ... 2016 conference in New York City . ... presenting at 10:30am at Pioneers 2016, a conference presented by ... New York Palace Hotel. The BiondVax presentation that ...
(Date:5/4/2016)... -- Yissum Research Development Company of ... it had signed an exclusive world-wide licensing and research ... protein degradation and immunomodulatory drugs for cancer and immune ... representing first-in-class therapy for hematologic and solid malignancies. Financial ... The novel technology was developed by Yinon Ben-Neriah ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Liposuction specialist Marcia V. Byrd, ... St. Louis, Missouri at the Marriot St. Louis Airport Hotel. This year’s conference was ... address the conference about her unique specialization in treating Lipedema. Dr. Byrd is considered ...
(Date:5/5/2016)... ... , ... Is the part in your hair widening? Are you finding more ... a good opportunity to raise awareness about a common condition among women: hair loss. ... women experience hair loss or ‘thinning’ by the time they reach menopause, but many ...
(Date:5/4/2016)... ... 04, 2016 , ... ProList is a set of 30 self-animating bullet points ... editors can easily create lists for presentations, youtube productions, and more. Simply choose ... is the perfect complement to presentation style videos. , ProList is a package of ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... and interview techniques, seeks to add a deeper understanding of the program, policy ... weaknesses, and each answers different yet important questions. , In a new brief ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... Business Conference. The conference opened on Tuesday with Frank Luntz, sharing a dynamic, ... PDMP Solution provided a deep dive on NCPDP’s model solution to help stem ...
Breaking Medicine News(10 mins):